罗欣药业(002793) - 2019 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2019 was ¥247,695,364.14, representing a 26.40% increase compared to ¥195,968,078.38 in the same period last year[8]. - Net profit attributable to shareholders decreased by 9.69% to ¥18,210,764.64 from ¥20,164,706.42 year-on-year[8]. - The net profit after deducting non-recurring gains and losses fell by 18.40% to ¥17,322,757.97 compared to ¥21,227,718.28 in the previous year[8]. - Sales revenue increased by 30.43% to ¥236,755,223.71, reflecting growth in sales volume[17]. - Total operating revenue for the current period reached ¥247,695,364.14, an increase of 26.4% compared to ¥195,968,078.38 in the previous period[38]. - Operating profit decreased to ¥20,963,694.99, down 8.8% from ¥22,995,797.22 year-over-year[40]. - Total profit for the current period was ¥20,986,344.08, a decrease of 5% from ¥23,145,223.97 in the previous period[40]. - Total comprehensive income for the current period was ¥18,210,205.53, down from ¥20,164,706.42 in the previous period[41]. Earnings and Shareholder Returns - Basic earnings per share decreased by 9.62% to ¥0.0911 from ¥0.1008 year-on-year[8]. - Diluted earnings per share fell by 19.15% to ¥0.0815 compared to ¥0.1008 in the same period last year[8]. - The weighted average return on equity decreased to 1.98% from 2.66% year-on-year[8]. Cash Flow and Liquidity - The net cash flow from operating activities improved significantly, reaching ¥16,270,273.28, a 166.24% increase from a negative cash flow of ¥24,563,269.90 in the same period last year[8]. - The company’s cash flow from operating activities increased significantly, with cash received from sales rising by 30.43%[17]. - Operating cash inflow totaled CNY 269,897,490.34, an increase of 28.8% compared to CNY 209,573,861.27 in the previous year[48]. - Cash flow from investing activities showed a net outflow of CNY 48,402,167.92, worsening from a net outflow of CNY 14,881,474.91 in the previous year[49]. - Cash flow from financing activities generated a net inflow of CNY 109,224,993.98, compared to a net outflow of CNY 6,920,689.87 last year[49]. - The total cash and cash equivalents at the end of the period reached CNY 391,115,658.13, up from CNY 74,482,138.15 at the end of the previous year[49]. Assets and Liabilities - Total assets increased by 9.87% to ¥1,540,061,993.10 from ¥1,401,732,445.47 at the end of the previous year[8]. - Current liabilities rose significantly to CNY 430,362,002.63, up from CNY 252,995,275.22, marking an increase of about 70.1%[36]. - The total liabilities increased to CNY 672,460,797.38 from CNY 497,623,020.21, indicating a rise of about 35%[36]. - The equity attributable to the owners of the parent company decreased to CNY 872,722,343.52 from CNY 908,558,169.75, a decline of approximately 3.9%[37]. - Total assets as of January 1, 2019, amounted to CNY 1,406,181,189.96, with total liabilities at CNY 497,623,020.21[60]. Expenses - Total operating costs amounted to ¥227,753,733.79, up 32.8% from ¥171,572,341.40 in the prior period[38]. - Research and development expenses rose by 36.82% to ¥8,956,123.36, indicating increased investment in innovation[16]. - Financial expenses increased by 58.58% to ¥10,037,999.92, mainly due to exchange losses from the depreciation of the US dollar against the RMB[16]. - The company experienced a 64.93% increase in selling expenses to ¥6,761,313.43, driven by domestic market expansion efforts[16]. - Investment income decreased by 135.08% to -¥87,082.50, due to reduced profits from copper futures contracts[16]. Other Financial Metrics - The company reported non-recurring gains totaling ¥888,006.67, which included government subsidies and investment income from financial assets[9]. - The company reported a fair value change gain of ¥992,350.00, compared to a loss of ¥1,741,000.00 in the previous period[40]. - The company incurred financial expenses of ¥10,037,999.92, an increase from ¥6,330,107.07 in the previous period[38]. - The company reported a deferred income of CNY 26,176,579.42 under non-current liabilities[60].